These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 32449811

  • 21. Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.
    Gan L, Chen S, Wang Y, Watahiki A, Bohrer L, Sun Z, Wang Y, Huang H.
    Cancer Res; 2009 Nov 01; 69(21):8386-94. PubMed ID: 19826044
    [Abstract] [Full Text] [Related]

  • 22. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH, Ku JY, Ha JM, Bae SS, Lee JZ, Kim CS, Ha HK.
    Prostate; 2017 Jan 01; 77(1):60-71. PubMed ID: 27550197
    [Abstract] [Full Text] [Related]

  • 23. LLT1-mediated activation of IFN-gamma production in human natural killer cells involves ERK signalling pathway.
    Bambard ND, Mathew SO, Mathew PA.
    Scand J Immunol; 2010 Mar 01; 71(3):210-9. PubMed ID: 20415786
    [Abstract] [Full Text] [Related]

  • 24. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.
    Lai KP, Huang CK, Chang YJ, Chung CY, Yamashita S, Li L, Lee SO, Yeh S, Chang C.
    Am J Pathol; 2013 Feb 01; 182(2):460-73. PubMed ID: 23219429
    [Abstract] [Full Text] [Related]

  • 25. Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Castration-resistant Prostate Cancer with Next generation Androgen Receptor Signal Inhibition: A Systematic Review and Meta-analysis.
    Li H, Wang Z, Tang K, Zhou H, Liu H, Yan L, Guan W, Chen K, Xu H, Ye Z.
    Eur Urol Focus; 2018 Jul 01; 4(4):529-539. PubMed ID: 28753843
    [Abstract] [Full Text] [Related]

  • 26. Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression.
    Shi L, Lin H, Li G, Jin RA, Xu J, Sun Y, Ma WL, Yeh S, Cai X, Chang C.
    Mol Cancer Ther; 2016 Apr 01; 15(4):731-742. PubMed ID: 26939703
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1.
    Roth P, Mittelbronn M, Wick W, Meyermann R, Tatagiba M, Weller M.
    Cancer Res; 2007 Apr 15; 67(8):3540-4. PubMed ID: 17440061
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis of curcumin derivatives targeting androgen receptor for castration-resistant prostate cancer therapy.
    Liu J, Ni Y, Zhou K, Wu G, Hu L, Zhu T, Xu D, Hu H.
    Chem Biol Drug Des; 2024 Jul 15; 104(1):e14583. PubMed ID: 38991995
    [Abstract] [Full Text] [Related]

  • 33. Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer.
    Moses MA, Kim YS, Rivera-Marquez GM, Oshima N, Watson MJ, Beebe KE, Wells C, Lee S, Zuehlke AD, Shao H, Bingman WE, Kumar V, Malhotra SV, Weigel NL, Gestwicki JE, Trepel JB, Neckers LM.
    Cancer Res; 2018 Jul 15; 78(14):4022-4035. PubMed ID: 29764864
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms.
    Centenera MM, Carter SL, Gillis JL, Marrocco-Tallarigo DL, Grose RH, Tilley WD, Butler LM.
    Endocr Relat Cancer; 2015 Oct 15; 22(5):805-18. PubMed ID: 26187127
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.